HARMONY OUTCOMES

Definition

The cardiovascular outcomes trial of albiglutide (Tanzeum) in 9,463 adults with type 2 diabetes and established cardiovascular disease. Hernandez and colleagues (Lancet 2018) reported a 22% relative reduction in MACE — but GSK had withdrawn albiglutide from global markets the year before the results were published due to low commercial uptake.

HARMONY OUTCOMES trial deep-dive →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in trial

• SURMOUNT-5
• SURMOUNT-2
• SURMOUNT-3
• SURPASS-2
• SUSTAIN-6
• REWIND
• PIONEER 6
• STEP-HFpEF
• EXSCEL
• ELIXA
• AMPLITUDE-O
• SCALE Diabetes
• STEP 2
• SUMMIT
• SCALE Maintenance

Looking for more depth?

• HARMONY OUTCOMES trial deep-dive
• Browse the full GLP-1 glossary (124 terms across 8 categories)
• Research articles — primary-source deep dives
• Tools and calculators
• Compare GLP-1 telehealth providers